Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2258)
All Articles published online
|
Oct 7, 2007 (publication date) through Nov 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hua D, Huang ZH, Mao Y, Deng JZ. Thymidylate synthase and thymidine phosphorylase gene expression as predictive parameters for the efficacy of 5-fluorouraci-based adjuvant chemotherapy for gastric cancer. World J Gastroenterol 2007; 13(37): 5030-5034 [PMID: 17854149 DOI: 10.3748/wjg.v13.i37.5030] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i37/5030.htm |
| Number | Citing Articles |
| 1 |
Zhao-Hui Huang, Dong Hua, Li-Hua Li. The polymorphisms of TS and MTHFR predict survival of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population. Cancer Chemotherapy and Pharmacology 2009; 63(5): 911 doi: 10.1007/s00280-008-0815-6
|
| 2 |
Mario Scartozzi, Elena Maccaroni, Riccardo Giampieri, Mirco Pistelli, Alessandro Bittoni, Michela Del Prete, Rossana Berardi, Stefano Cascinu. 5-Fluorouracil Pharmacogenomics: Still Rocking after all these years?. Pharmacogenomics 2011; 12(2): 251 doi: 10.2217/pgs.10.167
|
| 3 |
Kenji Ishido, Mizutomo Azuma, Wasaburo Koizumi, Atsuko Takeuchi, Shinichi Sakuramoto, Masahiko Watanabe, Isao Okayasu. Evaluation of prognostic factors for the response to S-1 in patients with stage II or III advanced gastric cancer who underwent gastrectomy. Pharmacogenetics and Genomics 2009; 19(12): 955 doi: 10.1097/FPC.0b013e328333351b
|
| 4 |
D Meulendijks, E A Rozeman, A Cats, K Sikorska, M Joerger, M J Deenen, J H Beijnen, J H M Schellens. Pharmacogenetic variants associated with outcome in patients with advanced gastric cancer treated with fluoropyrimidine and platinum-based triplet combinations: a pooled analysis of three prospective studies. The Pharmacogenomics Journal 2017; 17(5): 441 doi: 10.1038/tpj.2016.81
|
| 5 |
Dan Wang, Xuejun Yu, Xiuwen Wang. High/Positive Expression of 5-Fluorouracil Metabolic Enzymes Predicts Better Response to S-1 in Patients with Gastric Cancer: A Meta-Analysis. The International Journal of Biological Markers 2016; 31(2): 101 doi: 10.5301/jbm.5000202
|
| 6 |
Tingting Zhao, Zhi Xu, Dongying Gu, Peng Wu, Xinying Huo, Xiaowei Wei, Yongfei Tang, Weida Gong, Ming-Liang He, Jinfei Chen. The effects of genomic polymorphisms in one-carbon metabolism pathways on survival of gastric cancer patients received fluorouracil-based adjuvant therapy. Scientific Reports 2016; 6(1) doi: 10.1038/srep28019
|
| 7 |
Margaret Cho, Ogechukwu Eze, Ruliang Xu. Molecular genetics of gastric adenocarcinoma in clinical practice. World Journal of Medical Genetics 2014; 4(3): 58-68 doi: 10.5496/wjmg.v4.i3.58
|
| 8 |
Lukmon Raji, Angelina Tetteh, A. R. M. Ruhul Amin. Role of c-Src in Carcinogenesis and Drug Resistance. Cancers 2023; 16(1): 32 doi: 10.3390/cancers16010032
|
| 9 |
Yoshihisa Tateishi, Yukihiro Tatemoto, Seiji Ohno, Keiko Morishita, Eisaku Ueta, Tetsuya Yamamoto. Combined evaluation of dihydropyrimidine dehydrogenase and thymidine phosphorylate mRNA levels in tumor predicts the histopathological effect of 5-fluorouracil-based chemoradiotherapy. Cancer Letters 2009; 274(2): 187 doi: 10.1016/j.canlet.2008.09.010
|
| 10 |
Alessandro Morabito, Guido Carillio, Raffaele Longo. Systemic treatment of gastric cancer. Critical Reviews in Oncology/Hematology 2009; 70(3): 216 doi: 10.1016/j.critrevonc.2008.08.005
|
| 11 |
Tingting Zhao, Dongying Gu, Zhi Xu, Xinying Huo, Lili Shen, Chun Wang, Yongfei Tang, Peng Wu, Jason He, Weida Gong, Ming-Liang He, Jinfei Chen. Polymorphism in one-carbon metabolism pathway affects survival of gastric cancer patients: Large and comprehensive study. Oncotarget 2015; 6(11): 9564 doi: 10.18632/oncotarget.3259
|
| 12 |
Hua-Bin Hu, Lei Kuang, Xiao-Min Zeng, Bin Li, En-Yi Liu, Mei-Zuo Zhong. Predictive V16alue of Thymidylate Synthase Expression in Gastric Cancer: A Systematic Review with Meta-analysis. Asian Pacific Journal of Cancer Prevention 2012; 13(1): 261 doi: 10.7314/APJCP.2012.13.1.261
|
| 13 |
M.W. van Gisbergen, A.M. Voets, M.H.W. Starmans, I.F.M. de Coo, R. Yadak, R.F. Hoffmann, P.C. Boutros, H.J.M. Smeets, L. Dubois, P. Lambin. How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models. Mutation Research/Reviews in Mutation Research 2015; 764: 16 doi: 10.1016/j.mrrev.2015.01.001
|
| 14 |
Sara De Dosso, Elena Zanellato, Martina Nucifora, Renzo Boldorini, Angelica Sonzogni, Roberto Biffi, Nicola Fazio, Eraldo Bucci, Ottavio Beretta, Stefano Crippa, Piercarlo Saletti, Milo Frattini. ERCC1 predicts outcome in patients with gastric cancer treated with adjuvant cisplatin-based chemotherapy. Cancer Chemotherapy and Pharmacology 2013; 72(1): 159 doi: 10.1007/s00280-013-2181-2
|
| 15 |
Mario Scartozzi, Alessandro Bittoni, Mirco Pistelli, Eva Galizia, Rossana Berardi, Riccardo Giampieri, Luca Faloppi, Stefano Cascinu. Toward molecularly selected chemotherapy for advanced gastric cancer: State of the art and future perspectives. Cancer Treatment Reviews 2009; 35(5): 451 doi: 10.1016/j.ctrv.2009.04.008
|
| 16 |
A. Mirza, M. Brown, C. McNulty, J. Valentine, A. Annesley, S. Galloway, I. Welch, C. M. West, S. Pritchard. A Pilot Study to Investigate the Role of Thymidylate Synthase as a Marker of Prognosis for Neoadjuvant Chemotherapy in Gastric and Gastro-Oesophageal Junction Adenocarcinoma. Gastroenterology Research and Practice 2013; 2013: 1 doi: 10.1155/2013/502153
|
| 17 |
Jai N Patel, Charles S Fuchs, Kouros Owzar, Zihua Chen, Howard L McLeod. Gastric Cancer Pharmacogenetics: Progress or Old Tripe?. Pharmacogenomics 2013; 14(9): 1053 doi: 10.2217/pgs.13.88
|